Inhibitex to Present at Two Upcoming Conferences
August 25 2011 - 4:32PM
Business Wire
Inhibitex, Inc. (NASDAQ:INHX), a biopharmaceutical company
focused on developing products to treat and prevent serious
infectious diseases, announced that executive management is
scheduled to present an overview of the company and its pipeline at
the following two conferences:
-- Joseph M. Patti, senior vice president of research and
development and chief scientific officer, will present at the
Stifel Nicolaus Healthcare Conference, on Wednesday, September 7,
2011 at 2:40 pm EDT. The conference is being held at The Four
Seasons Hotel in Boston, Massachusetts.
-- Russell H. Plumb, president and chief executive officer, will
present at the JMP Securities Fifth Annul Healthcare Conference, on
Wednesday, September 28, 2011 at 8:30 am EDT. The conference is
being held at The St. Regis New York Hotel in New York, New
York.
The presentations will be simultaneously webcast and can be
accessed by visiting the Investors section of the Inhibitex website
at www.inhibitex.com. Shortly following the live webcast a
replay will also be available on the Company website.
About Inhibitex
Inhibitex, Inc. is a biopharmaceutical company focused on
developing products to prevent and treat serious infectious
diseases. The Company’s clinical-stage pipeline currently includes
two Phase 2 development programs; INX-189, a nucleotide polymerase
inhibitor in development for the treatment of chronic hepatitis C
infections and FV-100, a nucleoside analogue in development for the
treatment of shingles-associated pain. The Company also has
additional HCV nucleotide polymerase inhibitors in preclinical
development and has licensed the use of its proprietary MSCRAMM®
protein platform to Pfizer for the development of a staphylococcal
vaccine, which is currently being evaluated in a Phase 1 clinical
trial. For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex® and MSCRAMM® are registered trademarks of Inhibitex,
Inc.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024